Searchable abstracts of presentations at key conferences in endocrinology

ea0090pl2 | Diagnosis and management of paraganglioma | ECE2023

Diagnosis and management of paraganglioma

Young William F.

The first patient with a catecholamine-secreting paraganglioma that was sucessfully resected was in 1926. Over the past 97 years, there has been a dramatic evolution in the clinical presentation, methods used to diagnose and localize, and germline genetic testing of paragangliomas (PGLs). When contrasted to adrenal pheochromocytoma, PGLs present the clinician with unique challenges, which include: 1) diverse location—they may be located anywhere from the tympanic membrane...

ea0073pep11.6 | Presented ePosters 11: Adrenal and Cardiovascular Endocrinology | ECE2021

Increased risk of cardiometabolic disease in patients with benign adrenal tumours with and without cortisol excess: a case–control study

Prete Alessandro , Subramanian Anuradhaa , Bancos Irina , Sitch Alice J , Chortis Vasileios , Lang Katharina , Tsagarakis Stylianos , Macech Magdalena , Delivanis Danae A , O’Reilly Michael W , Masjkur Jimmy R , Quinkler Marcus , Ueland Grethe Å , Dennedy M Conall , Beuschlein Felix , Tabarin Antoine , Fassnacht Martin , Ivovic Miomira , Terzolo Massimo , Kastelan Darko , Young William F Jr , Manolopoulos Konstantinos N , Ambroziak Urszula , Vassiliadi Dimitra A , Nirantharakumar Krishnarajah , Arlt Wiebke

BackgroundBenign adrenocortical tumours are found in 3–5% of adults and can be non-functioning (NFAT) or associated with cortisol excess. The latter group divides into patients with clinically overt signs (adrenal Cushing’s syndrome, CS) and patients lacking CS signs (mild autonomous cortisol excess, MACE). The 1 mg-overnight dexamethasone suppression test (DST) further differentiates MACE into MACE-1 (possible MACE; post-DST cortisol 50–1...